{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:53:42Z","timestamp":1791233622446,"version":"4.1.0"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["JASN"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1681\/asn.0000001223","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T17:01:12Z","timestamp":1787072472000},"page":"2097-2099","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Dual B-Cell Maturation Antigen\/CD19 Chimeric Antigen Receptor-T Therapy for AL Amyloidosis"],"prefix":"10.1681","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2314-7892","authenticated-orcid":false,"given":"Klaudia","family":"Sobczak","sequence":"first","affiliation":[{"name":"Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts"},{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3111-0221","authenticated-orcid":false,"given":"Mark B.","family":"Leick","sequence":"additional","affiliation":[{"name":"Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts"},{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, Massachusetts"},{"name":"Broad Institute of Harvard University and Massachusetts Institute of Technology, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"issue":"1","key":"B1-20261005","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1056\/NEJMra1706169","article-title":"Chimeric antigen receptor therapy","volume":"379","author":"June","year":"2018","journal-title":"N Engl J Med."},{"issue":"6","key":"B2-20261005","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1038\/s41591-026-04430-6","article-title":"Resetting autoimmune disease with CAR cell therapies","volume":"32","author":"Schett","year":"2026","journal-title":"Nat Med."},{"issue":"8","key":"B3-20261005","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2308917","article-title":"CD19 CAR T-cell therapy in autoimmune disease - a case series with follow-up","volume":"390","author":"M\u00fcller","year":"2024","journal-title":"N Engl J Med."},{"issue":"6","key":"B4-20261005","doi-asserted-by":"crossref","first-page":"e424","DOI":"10.1016\/S2665-9913(25)00091-8","article-title":"Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with autoimmune disease: an observational study","volume":"7","author":"Hagen","year":"2025","journal-title":"Lancet Rheumatol."},{"issue":"19","key":"B5-20261005","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1182\/blood.2020008737","article-title":"How I treat AL amyloidosis","volume":"139","author":"Palladini","year":"2022","journal-title":"Blood."},{"issue":"6","key":"B6-20261005","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1038\/s41591-025-03718-3","article-title":"BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cells","volume":"31","author":"M\u00fcller","year":"2025","journal-title":"Nat Med."},{"issue":"1","key":"B7-20261005","doi-asserted-by":"crossref","first-page":"eaeb6424","DOI":"10.1126\/sciadv.aeb6424","article-title":"BCMA\/CD19 CAR T cell therapy for refractory myasthenia gravis: proteomic signatures and single-cell transcriptomics of disease flares","volume":"12","author":"Huang","year":"2026","journal-title":"Sci Adv."},{"issue":"10","key":"B8-20261005","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1681\/ASN.0000001096","article-title":"B-cell maturation antigen-CD19 dual-targeted chimeric antigen receptor-T\u2013cell therapy for relapsed or refractory AL amyloidosis","volume":"37","author":"Huang","year":"2026","journal-title":"J Am Soc Nephrol"},{"issue":"20","key":"B9-20261005","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1182\/blood.2024024166","article-title":"Second primary malignancies after commercial CAR T-cell therapy: analysis of the FDA adverse events reporting system","volume":"143","author":"Elsallab","year":"2024","journal-title":"Blood."},{"issue":"6","key":"B10-20261005","first-page":"372","article-title":"Mechanisms of resistance to CAR T cell therapy","volume":"16","author":"Shah","year":"2019","journal-title":"Nat Rev Clin Oncol."},{"issue":"16_suppl l","key":"B11-20261005","doi-asserted-by":"crossref","first-page":"7509","DOI":"10.1200\/JCO.2026.44.16_suppl.7509","article-title":"Updated results from inMMyCAR, the ongoing first-in-human phase 1 study of KLN-1010 in patients (pts) with relapsed and refractory multiple myeloma (RRMM)","volume":"44","author":"Ho","year":"2026","journal-title":"J Clin Oncol."}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.0000001223","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:00:41Z","timestamp":1791230441000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.0000001223"}},"subtitle":["Targeting the Clone, Saving the Kidney"],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":11,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.0000001223","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]}}}